Genetic initiation of hypertensive and diabetic nephropathy.

[1]  B. Freedman,et al.  Family history of end-stage renal disease among incident dialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.

[2]  W. Grzeszczak,et al.  Nephropathy of type II diabetes: evidence for hereditary factors? , 1997, Kidney international.

[3]  S. Rich,et al.  Linkage of Genetic Markers on Human Chromosomes 20 and 12 to NIDDM in Caucasian Sib Pairs With a History of Diabetic Nephropathy , 1997, Diabetes.

[4]  B. Freedman,et al.  Familial clustering of end-stage renal disease in blacks with lupus nephritis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  D. Fliser,et al.  Renal function in the elderly: impact of hypertension and cardiac function. , 1997, Kidney international.

[6]  S. Rich,et al.  Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. , 1997, Kidney international.

[7]  J. Breyer,et al.  Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. , 1997, Kidney international.

[8]  S. Rich,et al.  Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. , 1996, Journal of the American Society of Nephrology : JASN.

[9]  G. Gearin,et al.  Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. , 1996, Journal of the American Society of Nephrology : JASN.

[10]  D. Warnock,et al.  Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  M. Daly,et al.  Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat , 1996, Nature Genetics.

[12]  R. Toto,et al.  "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. , 1995, Kidney international.

[13]  A. Goldberg,et al.  Salt-Induced Increases in Systolic Blood Pressure Affect Renal Hemodynamics and Proteinuria , 1995 .

[14]  B. Freedman,et al.  Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  A. Goldberg,et al.  Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. , 1995, Hypertension.

[16]  J. Beckmann,et al.  A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q , 1995, Nature Genetics.

[17]  B. Freedman,et al.  The link between hypertension and nephrosclerosis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  P. Whelton,et al.  Diagnosis of hypertensive end-stage renal disease: effect of patient's race. , 1995, American journal of epidemiology.

[19]  D. Clayton,et al.  Linkage of the angiotensinogen gene to essential hypertension. , 1994, The New England journal of medicine.

[20]  J. Curtis,et al.  Clinical documentation of end-stage renal disease due to hypertension. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[22]  J. Lalouel,et al.  Angiotensinogen as a risk factor for essential hypertension in Japan. , 1994, The Journal of clinical investigation.

[23]  A. Krolewski,et al.  Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy. , 1994, Kidney international. Supplement.

[24]  L. Groop,et al.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria , 1994 .

[25]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[26]  B. Freedman,et al.  The familial risk of end-stage renal disease in African Americans. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  R. Neuwirth,et al.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. , 1992, JAMA.

[28]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.

[29]  H. Parving,et al.  Is diabetic nephropathy an inherited complication? , 1992, Kidney international.

[30]  S. Antonarakis,et al.  Linkage analysis of maturity-onset diabetes of the young (MODY): genetic heterogeneity and nonpenetrance. , 1992, American journal of human genetics.

[31]  J. Beckmann,et al.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[32]  V. Campese,et al.  Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension , 1991, Hypertension.

[33]  P. Whelton,et al.  Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? , 1991, Archives of internal medicine.

[34]  N J Cox,et al.  Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[36]  H. Dustan,et al.  Renal insufficiency in treated essential hypertension. , 1989, The New England journal of medicine.

[37]  W. Stead,et al.  Progression of renal insufficiency: role of blood pressure. , 1989, Kidney international.

[38]  W. McClellan,et al.  Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  C. Grim,et al.  A familial risk of chronic renal failure among blacks on dialysis? , 1988, Journal of clinical epidemiology.

[40]  W. Knowler,et al.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[41]  C. E. Mogensen.  Microalbuminuria as a predictor of clinical diabetic nephropathy. , 1987, Kidney international.

[42]  N. Fineberg,et al.  Definitions and Characteristics of Sodium Sensitivity and Blood Pressure Resistance , 1986, Hypertension.

[43]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Brenner Bm.  Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. , 1983 .

[45]  B. Brenner,et al.  Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. , 1983, Kidney international.

[46]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.

[47]  T Reich,et al.  The generalized sib pair IBD distribution: its use in the detection of linkage , 1978, Annals of human genetics.

[48]  Professor Dr. Hans Ulrich Zollinger,et al.  Renal Pathology in Biopsy , 1978, Springer Berlin Heidelberg.

[49]  O. Cope,et al.  STUDIES ON THE PHYSIOLOGY OF THE PARATHYROID GLANDS. IV. RENAL COMPLICATIONS OF HYPERPARATHYROIDISM , 1934 .